NADAC acquisition cost data for SILVER SULFADIAZINE 1% CREAM. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | Silver Sulfadiazine |
| Brand Name | Silver Sulfadiazine |
| Manufacturer | Asclemed USA, Inc. |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Pharmacologic Class | Sulfonamide Antibacterial |
| Product Type | HUMAN PRESCRIPTION DRUG |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 59762013104 | $0.0781 | 2022-12-21 | Rx |
| 67877012440 | $0.0781 | 2022-12-21 | Rx |
| 59762013108 | $0.1244 | 2022-12-21 | Rx |
| 67877012485 | $0.1244 | 2022-12-21 | Rx |
| 59762013105 | $0.1317 | 2022-12-21 | Rx |
| 59762013106 | $0.1317 | 2022-12-21 | Rx |
| 67877012405 | $0.1317 | 2022-12-21 | Rx |
| 67877012450 | $0.1317 | 2022-12-21 | Rx |
| 59762013102 | $0.1741 | 2022-12-21 | Rx |
| 67877012425 | $0.1741 | 2022-12-21 | Rx |
Generic: Silver Sulfadiazine | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $52.0K | 2,251 | 1,784 | $0.1871 |
| 2020 | $48.5K | 2,120 | 1,707 | $0.1839 |
| 2021 | $36.7K | 1,447 | 1,176 | $0.1775 |
| 2022 | $29.3K | 971 | 828 | $0.1619 |
| 2023 | $31.2K | 1,100 | 925 | $0.1837 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| California | $5.0K | 192 | 164 |
| Florida | $4.4K | 105 | 84 |
| New York | $2.5K | 98 | 79 |
| Illinois | $1.8K | 47 | 37 |
| Texas | $1.5K | 54 | 51 |
| Ohio | $986.57 | 43 | 37 |
| Pennsylvania | $946.69 | 49 | 44 |
| Michigan | $936.28 | 36 | 32 |
| Missouri | $880.03 | 28 | 26 |
| Puerto Rico | $801.59 | 21 | 16 |
| North Carolina | $784.49 | 31 | 28 |
| Kentucky | $733.34 | 21 | 20 |
| Louisiana | $650.05 | 29 | 18 |
| Georgia | $644.33 | 29 | 26 |
| Indiana | $633.36 | 26 | 15 |
| Wisconsin | $622.55 | 13 | 13 |
| Maryland | $605.06 | 11 | 11 |
| Arizona | $592.68 | 18 | 16 |
| South Carolina | $545.45 | 20 | 17 |
| Oklahoma | $453.21 | 20 | 16 |
| New Jersey | $436.80 | 22 | 21 |
| West Virginia | $409.18 | 16 | 11 |
| Oregon | $374.70 | 15 | 11 |
| Iowa | $365.80 | 13 | N/A |
| Connecticut | $353.12 | 25 | 14 |
| Alabama | $341.33 | 15 | 15 |
| Tennessee | $306.60 | 14 | 12 |
| Virginia | $225.53 | 15 | 13 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.